Although tau pathology in human AD and tauopathies are similar in terms of an increase in tau NFT pathology, key differences exist in terms of the rate of disease progression, cell types affected by tau pathology and the site of initiation and spread of tau pathology, and the forms of tau that are present in the insoluble aggregates. This evidence concerns the gene MAPT and Alzheimer disease.